If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 1 - 2 of 2
A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Eltrekibart in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Objective
Eltrekibart in Adults with Moderate to Severe Hidradenitis Suppurativa
Protocol No
DERM-ELILILLY-I7P-MC-DSAF
Categories
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Objective
Subcutaneous Sonelokimab v Placebo in Moderate to Severe Hidradenitis Suppurativa
Protocol No
DERM-MOONLAKE-M1095-HS-302
Categories